Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
Center for Genomic Medicine, Massachusetts General Hospital, Harvard Medical School, Boston.
JAMA Netw Open. 2022 Mar 1;5(3):e223849. doi: 10.1001/jamanetworkopen.2022.3849.
Observational studies have consistently proposed cardiovascular benefits associated with light alcohol consumption, while recent genetic analyses (ie, mendelian randomization studies) have suggested a possible causal link between alcohol intake and increased risk of cardiovascular disease. However, traditional approaches to genetic epidemiology assume a linear association and thus have not fully evaluated dose-response estimates of risk across different levels of alcohol intake.
To assess the association of habitual alcohol intake with cardiovascular disease risk and to evaluate the direction and relative magnitude of cardiovascular risk associated with different amounts of alcohol consumption.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study used the UK Biobank (2006-2010, follow-up until 2016) to examine confounding in epidemiologic associations between alcohol intake and cardiovascular diseases. Using both traditional (ie, linear) and nonlinear mendelian randomization, potential associations between alcohol consumption and cardiovascular diseases (eg, hypertension and coronary artery disease) as well as corresponding association shapes were assessed. Data analysis was conducted from July 2019 to January 2022.
Genetic predisposition to alcohol intake.
The association between alcohol consumption and cardiovascular diseases, including hypertension, coronary artery disease, myocardial infarction, stroke, heart failure, and atrial fibrillation.
This study included 371 463 participants (mean [SD] age, 57.0 [7.9] years; 172 400 [46%] men), who consumed a mean (SD) 9.2 (10.6) standard drinks per week. Overall, 121 708 participants (33%) had hypertension. Light to moderate alcohol consumption was associated with healthier lifestyle factors, adjustment for which attenuated the cardioprotective epidemiologic associations with modest intake. In linear mendelian randomization analyses, a 1-SD increase in genetically predicted alcohol consumption was associated with 1.3-fold (95% CI, 1.2-1.4) higher risk of hypertension (P < .001) and 1.4-fold (95% CI, 1.1-1.8) higher risk of coronary artery disease (P = .006). Nonlinear mendelian randomization analyses suggested nonlinear associations between alcohol consumption and both hypertension and coronary artery disease: light alcohol intake was associated with minimal increases in cardiovascular risk, whereas heavier consumption was associated with exponential increases in risk of both clinical and subclinical cardiovascular disease.
In this cohort study, coincident, favorable lifestyle factors attenuated the observational benefits of modest alcohol intake. Genetic epidemiology suggested that alcohol consumption of all amounts was associated with increased cardiovascular risk, but marked risk differences exist across levels of intake, including those accepted by current national guidelines.
观察性研究一致提出了与轻度饮酒相关的心血管益处,而最近的遗传分析(即孟德尔随机化研究)表明,饮酒与心血管疾病风险增加之间可能存在因果关系。然而,传统的遗传流行病学方法假设存在线性关联,因此尚未充分评估不同饮酒水平下风险的剂量-反应估计。
评估习惯性饮酒与心血管疾病风险的关联,并评估与不同饮酒量相关的心血管风险的方向和相对程度。
设计、地点和参与者:这项队列研究使用英国生物库(2006-2010 年,随访至 2016 年),以评估饮酒与心血管疾病之间的流行病学关联中的混杂因素。使用传统(即线性)和非线性孟德尔随机化,评估了饮酒与心血管疾病(如高血压和冠状动脉疾病)之间的潜在关联以及相应的关联形状。数据分析于 2019 年 7 月至 2022 年 1 月进行。
酒精摄入的遗传易感性。
饮酒与心血管疾病(包括高血压、冠状动脉疾病、心肌梗死、中风、心力衰竭和心房颤动)之间的关联。
本研究纳入了 371463 名参与者(平均[标准差]年龄为 57.0[7.9]岁;172400[46%]为男性),每周平均(标准差)饮用 9.2(10.6)标准饮品。总体而言,有 121708 名参与者(33%)患有高血压。轻度至中度饮酒与更健康的生活方式因素有关,调整这些因素后,适度饮酒的心血管保护流行病学关联减弱。在线性孟德尔随机化分析中,遗传预测的饮酒量每增加 1 个标准差,高血压的风险就会增加 1.3 倍(95%CI,1.2-1.4)(P<.001),冠状动脉疾病的风险增加 1.4 倍(95%CI,1.1-1.8)(P=0.006)。非线性孟德尔随机化分析表明,饮酒与高血压和冠状动脉疾病之间存在非线性关联:轻度饮酒与心血管风险的适度增加相关,而较重的饮酒与临床和亚临床心血管疾病风险的指数增加相关。
在这项队列研究中,一致的、有利的生活方式因素减弱了适度饮酒的观察益处。遗传流行病学表明,所有量的饮酒都与心血管风险增加有关,但摄入量水平存在明显的风险差异,包括当前国家指南所接受的水平。